Lion Biotechnologies (LBIO) 7.98 $LBIO TroyGould Closes

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Lion Biotechnologies (LBIO) 7.98 $LBIO

TroyGould Closes $100 Million Lion Biotech Deal
PR Newswire - Wed Jun 15, 12:00PM CDT
TroyGould today announced that it represented its client, Lion Biotechnologies, Inc. (LBIO), which is in clinical trials with an innovative immunotherapy treatment for solid tumors, in a $100 million financing.
LBIO: 7.98 (+0.24)

Lion Biotechnologies' Annual Meeting Rescheduled
Marketwired - Wed Jun 08, 3:05PM CDT
NEW YORK, NY--(Marketwired - June 08, 2016) - Lion Biotechnologies, Inc. (NASDAQ: LBIO), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TILs), today announced that its Board of Directors will reschedule the company's 2016 Annual Meeting of Stockholders, which was originally scheduled for Friday, June 10, 2016.
LBIO: 7.98 (+0.24)

Lion Biotechnologies Announces Closing of $100 Million Private Financing
Marketwire Canada - Wed Jun 08, 7:01AM CDT
NEW YORK, NY--(Marketwired - June 08, 2016) - Lion Biotechnologies, Inc. (NASDAQ: LBIO) announced today the closing of its previously announced private financing with institutional and other accredited investors. Lion Biotechnologies received gross proceeds of $100 million, before paying the placement agents' fees and estimated offering expenses payable by the Company. At the closing, the Company issued 9,684,000 shares of common stock and 11,368,633 shares of its new non-voting Series B Preferred Stock.
LBIO: 7.98 (+0.24)

Lion Biotechnologies to Present at the Jefferies 2016 Healthcare Conference
Marketwire Canada - Fri Jun 03, 10:15AM CDT
NEW YORK, NY--(Marketwired - June 03, 2016) - Lion Biotechnologies, Inc. (NASDAQ: LBIO), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TILs), announced today that Lion management will present a company overview at the upcoming Jefferies 2016 Healthcare Conference on Tuesday, June 7, 2016 at 2:30pm E.T in New York, NY.
LBIO: 7.98 (+0.24)

Lion Biotechnologies Appoints Maria Fardis, Ph.D., as CEO
Marketwired - Fri Jun 03, 8:34AM CDT
NEW YORK, NY--(Marketwired - June 03, 2016) -
LBIO: 7.98 (+0.24)

Lion Biotechnologies Raises Approximately $100 Million in Private Placement
Marketwire Canada - Fri Jun 03, 8:31AM CDT
NEW YORK, NY--(Marketwired - June 03, 2016) - Lion Biotechnologies, Inc. (NASDAQ: LBIO) today announced that it has entered into a securities purchase agreement with institutional and other accredited investors under which the investors have agreed to purchase a total of 9,684,000 shares of common stock and approximately 11,368,500 shares of newly authorized Series B Preferred Stock in a private placement for aggregate gross proceeds of approximately $100.0 million. The purchase price will be $4.75 for each share of common stock and $4.75 for each share of Series B Preferred Stock. The offering is expected to close on or about June 7, 2016, subject to customary closing conditions.
LBIO: 7.98 (+0.24)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of Lion Biotechnologies, Inc. - LBIO
PR Newswire - Mon May 23, 3:23PM CDT
Levi & Korsinsky announces it has commenced an investigation of Lion Biotechnologies, Inc. (NASDAQ: LBIO) concerning possible breaches of fiduciary duty by the board of directors of the company. To obtain additional information, go to:
LBIO: 7.98 (+0.24)

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Lion Biotechnologies, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
PR Newswire - Mon May 23, 6:42AM CDT
Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Lion Biotechnologies, Inc. (NASDAQ: LBIO).
LBIO: 7.98 (+0.24)

Lion Biotechnologies reports 1Q loss
Automated Insights - Mon May 09, 7:10AM CDT
NEW YORK (AP) _ Lion Biotechnologies Inc. (LBIO) on Monday reported a loss of $6.9 million in its first quarter.
LBIO: 7.98 (+0.24)

Lion Biotechnologies Announces First Quarter 2016 Financial Results
Marketwired - Mon May 09, 7:01AM CDT
NEW YORK, NY --(Marketwired - May 09, 2016) - Lion Biotechnologies, Inc. (NASDAQ: LBIO), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TILs), today reported its first quarter 2016 financial results and provided a corporate update.
LBIO: 7.98 (+0.24)

Lion Biotechnologies Manufacturing Capabilities and Research Programs Unaffected by Review of National Cancer Institute's Manufacturing Facilities
Marketwired - Sun Apr 17, 10:00AM CDT
Lion Biotechnologies, Inc. (NASDAQ: LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TILs), announced that it has learned that the cell therapy manufacturing facilities at the National Cancer Institute (NCI) are undergoing a voluntary internal review by the National Institutes of Health (NIH) in connection with the NIH's review of all NCI facilities involving sterile material. TIL studies conducted by the NCI are among those suspended until the review is complete.
LBIO: 7.98 (+0.24)

Lion Biotechnologies Names Michael T. Lotze Chief Scientific Officer
Marketwired - Mon Mar 28, 7:01AM CDT
Lion Biotechnologies, Inc. (NASDAQ: LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TIL), today announced the appointment of Michael T. Lotze, MD, as chief scientific officer (CSO) and vice president of research and development, effective immediately.
LBIO: 7.98 (+0.24)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Purina Institute Highlights Nutritional Science at WSAVA 2026

Updated Category News Views 7

A Global Stage for Pet Nutrition Science The folks over at the Purina Institute are back in the spotlight as they gear up to throw their weight behind the 51st World Small Animal Veterinary Association (WSAVA) Congress in Warsaw, Poland. Set for October 13-15, 2026, this isn’t just another event—they're bringing some serious clout with their 'Food for Thought'...

Continue Reading
Navigating Holiday Sweets: Healthy Balancing Acts

Updated Category News Views 3

In the middle of the sweet madness that is the holiday season, Crispy Green and Dr. Nicole Avena are playing guide to families drowning in sugar. This isn't just a once-a-year Halloween headache; we're starting that sugar spiral early and letting it ride until the New Year approaches. It's an all-hands-on-deck situation if families want to dodge that sugar overload. Why...

Continue Reading
Karoo Health Leaps Forward with New CCO Breton

Updated Category News Views 5

Change of Guard in Cardiac Health at Karoo Here's a move that might shake things up in the healthtech sector: Karoo Health just snagged Angela "Angie" Breton as their new Chief Commercial Officer. It's like putting a seasoned captain at the helm right before setting sail on uncharted waters. Breton's not just any captain—she's got a hefty 25 years of experience...

Continue Reading
TA Services Strengthens U.S.-Mexico Freight Operations

Updated Category News Views 3

TA Services Moves Boldly Across Borders If ever there was a time to play the logistics chessboard like a champ, it's now, and TA Services just slammed the board with a solid move. They've grabbed Carmen Pacheco Transportation and Interload Forwarding, two family-run operations with some real muscle in North American logistics. This isn't a small-time maneuver; they've...

Continue Reading
ROKFORM’s Signal Card: A Wallet Tracker for All

Updated Category News Views 4

The Gadget You Didn't Know You Needed Ever feel that momentary panic when your wallet seems to have vanished into thin air? ROKFORM's fresh offering, the Signal Card, tackles that heart-stopping moment head-on. They've taken the mundane act of misplacing your wallet and transformed it with their sleek, credit-card-sized tracker. This baby pairs seamlessly with Apple Find...

Continue Reading
Dentistry.One Achieves HITRUST i1, Boosts Cybertrust

Updated Category News Views 2

HITRUST i1 Certification: The Gold Standard in Security For a world increasingly reliant on digital infrastructure, cybersecurity certification is no longer just a badge of honor; it's a cornerstone of trust. Dentistry.One nailed this down by bagging that coveted HITRUST i1 certification. When folks talk about securing data, HITRUST might as well be speaking gospel. We're...

Continue Reading
JiMMYBAR! Expands Creatine Market with Target Launch

Updated Category News Views 8

JiMMYBAR! Breaks New Ground in Supplements You ever notice how some companies just know how to shake things up? Take JiMMYBAR!, for instance. The moment I read they’re making moves to get their Creatine + Protein bars into Target stores nationwide, starting October 4, I thought, “That’s one way to drag creatine out from the dusty tub and onto the shelves of...

Continue Reading
Truss Financial Tackles Home Equity Closing Delays

Updated Category News Views 4

Truss Financial Group's Bold Move Against Closing Delays In real estate, time is money. Even the most casual market observer could tell you delays can slice through a deal like a hot knife through butter. That's the headache home equity borrowers face, blindsided by closing delays that sneak up on them without warning. An Industry Bottleneck Finally Addressed Enter Truss...

Continue Reading
Cure Blindness Project's 770K Screenings for World Sight Day

Updated Category News Views 5

Visionary Steps Toward a Brighter Future No two words could describe the task that Cure Blindness Project is tackling this year: vision and action. Marking World Sight Day on October 8, they plan to usher in 770,000 eye screenings across Asia, Africa, and the Caribbean. These initiatives aren't just numbers—they're a colossal step toward lifting the veil of avoidable...

Continue Reading
Pushing for National Liver Cancer Awareness in 2026

Updated Category News Views 4

The Urgency of Liver Cancer Awareness Death doesn’t wait, does it? When liver cancer is the villain in question, every moment becomes precious because this beast doesn’t roar until it’s too late. Here we are in 2026, staring at nearly 31,000 annual deaths in the U.S. alone. But hope flickers with a new congressional resolution aiming to slap a bright spotlight on...

Continue Reading

Top 5 Most Recently Viewed Articles

Havis Unveils Next-Gen Solutions at NRF 2025 Conference

Updated Category News Views 214

Exciting Innovations from Havis at NRF 2025 Havis, a renowned provider of technology mounting and mobility solutions, is set to make a significant impact at the upcoming National Retail Federation (NRF) 2025 Conference & Expo. The event, scheduled to take place from January 12 to 14 at the Jacob K. Javits Convention Center, will be a platform for Havis to showcase its...

Continue Reading
Amcor Secures European Patent for Innovative Paper Packaging

Updated Category News Views 220

Amcor's Patented AmFiber Packaging Technology Amcor, a global leader in sustainable packaging solutions, has proudly received a European patent for its groundbreaking paper packaging, known as AmFiber Performance Paper. This innovative packaging solution features a thin film barrier that enhances its unique characteristics, making it suitable for food and healthcare-grade...

Continue Reading
Experience K-Beauty Like Never Before at KCON 2025

Updated Category News Views 417

Join COSRX at KCON LA 2025 for an Unforgettable Experience The renowned K-Beauty brand COSRX is gearing up to dazzle attendees at KCON LA 2025 with an impressive booth set to provide skincare enthusiasts and K-pop fans a unique opportunity. Expect an immersive experience showcasing the brand's most-loved products. This exciting event is slated to occur at the Los Angeles...

Continue Reading
Solstice Advanced Materials Engages in Significant Discussion

Updated Category News Views 98

Solstice Advanced Materials Engages in Significant Discussion Solstice Advanced Materials (NASDAQ: SOLS) is stepping into the spotlight as David Sewell, the President and CEO, prepares to engage in a thought-provoking fireside chat at the Barclays Industrial Select Conference. This event is not just an opportunity for sharing information; it’s a vital moment for...

Continue Reading
Paul Ryan to Lead Vertiv in EMEA from January 2026

Updated Category News Views 196

Leadership Changes at Vertiv Vertiv, a prominent player in critical digital infrastructure, is undergoing a significant leadership transition. As of January 1, 2026, Paul Ryan will take the helm as the president for the Europe, Middle East, and Africa (EMEA) region. This strategic shift comes as Karsten Winther decides to retire from his role as president of EMEA,...

Continue Reading